Ginkgo Bioworks gears up for $17.5bn merger
The Illumina-backed microbial technology producer will list on the Nasdaq Capital Market through the reverse takeover transaction.
Plus pursues $3.3bn reverse takeover
The SAIC, Wanxiang, Full Truck Alliance and Quanta Computer-backed autonomous trucking technology developer will list on the Nasdaq Capital Market through the deal.
Ane Logistics announces Hong Kong IPO
The LTL shipping network operator is reportedly targeting $500m in the listing, which would enable corporates Ping An and Yili to exit.
Benson Hill tends to public listing
The GV, Louis Dreyfus Company and Emart-backed food development platform creator is pursuing a reverse takeover at a $1.35bn valuation.
ESS charges up $1.1bn reverse merger
SoftBank vehicle SB Energy and BASF contributed to a $250m PIPE financing that will support the merger with the Nasdaq-listed Acon S2 Acquisition Corp.
Singular Genomics to mingle with public markets
The genetic sequencing technology developer has filed to raise up to $100m, having secured nearly $150m from investors including Legend Capital in the past two years.
Waterdrop mops up $360m in IPO
The Meituan Dianping, Tencent and Swiss Re-backed health insurance marketplace operator priced its offering at the top of its range.
Jasper Therapeutics jumps at reverse merger opportunity
Roche Venture Fund and Amgen will invest in the stem cell-transplant technology developer through a reverse merger transaction which will give it a $490m market capitalisation.

Other News

Science 37 experiments with reverse takeover
The Sanofi, Amgen, Alphabet, Novartis and PPD-backed clinical trials software producer is joining forces with publicly listed LifeSci Acquisition II Corp.
Gyroscope Therapeutics gives up $149m IPO
The Fosun-backed gene therapy developer had set terms for an offering set to raise between $135m and $149m on the Nasdaq Global Select Market.
Day One initiates IPO process
The Takeda and Access Industries-backed oncology therapeutics developer is targeting an offering on the Nasdaq Global Market having previously raised $190m.
AEye amends reverse merger deal downwards
The corporate-backed lidar technology provider will now be valued at $1.52bn pre-acquisition rather than the $1.9bn figure when the deal was announced in February.
Expensify confidentially files to go public
Barracuda Networks could be in line to exit the accountancy software producer, which had disclosed more than $31m in funding through 2015.
Roivant engineers $7.3bn reverse takeover
Dexxon, SoftBank and Sumitomo Dainippon-backed medical company builder Roivant Sciences will get a public listing through the transaction.

Editor's Picks

Sonder sends out $2.2bn reverse merger plans
The Lennar-backed accommodation provider will take a Nasdaq listing having previously raised $530m, and was valued at $1.3bn as of June 2020.
Zomato sums up $1.1bn IPO plans
The food ordering app developer's largest shareholder, Info Edge, is set to sell $100m of shares in the proposed dual offering.
UiPath reaches public markets
CapitalG is selling $85.5m of shares in the robotic process automation technology producer as part of an offering sized at almost $1.34bn.
TuSimple delivers $1.35bn initial public offering
The CN, Goodyear, Kroger, Mando, Navistar, Nvidia, Sina, Traton, Union Pacific, UPS and US Xpress-backed autonomous truck producer was valued at more than $8.5bn in the IPO.
test reg